Mechanisms and in vitro models of drug-induced cholestasis.
Drug-induced cholestasis
In vitro models
Liver
Mechanisms
Journal
Archives of toxicology
ISSN: 1432-0738
Titre abrégé: Arch Toxicol
Pays: Germany
ID NLM: 0417615
Informations de publication
Date de publication:
05 2019
05 2019
Historique:
received:
26
11
2018
accepted:
02
04
2019
pubmed:
12
4
2019
medline:
3
7
2020
entrez:
12
4
2019
Statut:
ppublish
Résumé
Cholestasis underlies one of the major manifestations of drug-induced liver injury. Drug-induced cholestatic liver toxicity is a complex process, as it can be triggered by a variety of factors that induce 2 types of biological responses, namely a deteriorative response, caused by bile acid accumulation, and an adaptive response, aimed at removing the accumulated bile acids. Several key events in both types of responses have been characterized in the past few years. In parallel, many efforts have focused on the development and further optimization of experimental cell culture models to predict the occurrence of drug-induced cholestatic liver toxicity in vivo. In this paper, a state-of-the-art overview of mechanisms and in vitro models of drug-induced cholestatic liver injury is provided.
Identifiants
pubmed: 30972450
doi: 10.1007/s00204-019-02437-2
pii: 10.1007/s00204-019-02437-2
doi:
Substances chimiques
Bile Acids and Salts
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1169-1186Subventions
Organisme : European Research Council
ID : Starting Grant
Pays : International
Organisme : Center for Alternatives to Animal Testing, Johns Hopkins Bloomberg School of Public Health
ID : Project Grant
Pays : International
Organisme : Fund for Scientific Research-Flanders
ID : Project Grant
Pays : International
Organisme : Willy Gepts Fonds UZ-Brussels
ID : Project Grant
Pays : International